Next Article in Journal
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185”
Previous Article in Journal
Integrating UHPLC-QE-MS and Bioinformatics with Experimental Validation Reveals MAPK/FOS-Mediated Podocyte Apoptosis as the Key Mechanism of Alpiniae oxyphyllae and Saposhnikovia divaricata in Treating Diabetic Kidney Disease
 
 
Comment

Article Versions Notes

Pharmaceuticals 2025, 18(10), 1450; https://doi.org/10.3390/ph18101450
Action Date Notes Link
article xml file uploaded 28 September 2025 10:23 CEST Original file -
article xml uploaded. 28 September 2025 10:23 CEST Update https://www.mdpi.com/1424-8247/18/10/1450/xml
article pdf uploaded. 28 September 2025 10:23 CEST Version of Record https://www.mdpi.com/1424-8247/18/10/1450/pdf
article html file updated 28 September 2025 10:25 CEST Original file https://www.mdpi.com/1424-8247/18/10/1450/html
Back to TopTop